Related Experiment Videos
Thyroid activity during hepatocarcinogenesis by N-2-fluorenylacetamide.
Journal of Cancer Research and Clinical Oncology
|January 1, 1981
Summary
Chemicals alter female rat thyroid activity, lowering thyroid hormones (T4 and T3). This hormonal change may protect females from liver cancer, unlike males.
Area of Science:
- Endocrinology
- Toxicology
- Carcinogenesis
Background:
- N-2-fluorenylacetamide (2-FAA) is a chemical carcinogen.
- Hormonal status is significantly altered during chemical carcinogenesis.
- Female Sprague Dawley rats exhibit distinct responses to chemical exposure compared to males.
Purpose of the Study:
- To investigate the impact of N-2-fluorenylacetamide on the hormonal status of female rats.
- To correlate thyroid and pituitary gland activity with serum thyroid hormone levels.
- To explore the potential role of hormonal changes in sex-based differences in chemical-induced liver cancer.
Main Methods:
- Histological examination of thyroid and pituitary glands.
- Assays for serum thyroxine (T4) and triiodothyronine (T3) levels.
- Observation of Sprague Dawley rats during chemical carcinogenesis.
Main Results:
- Thyroid glands showed modified activity, evidenced by histological changes and altered T4 and T3 levels.
- Pituitary thyrotropic cells were hyperactive, consistent with thyroid gland hyperactivity.
- Serum T4 levels were decreased, and T3 levels were decreased to a lesser extent in exposed females.
- Female rats exhibited a relative protection against liver cancer induction compared to males.
Conclusions:
- Chemical carcinogenesis by N-2-fluorenylacetamide significantly modifies thyroid function in female rats.
- Lowered serum thyroid hormone levels (T4 and T3) in females may contribute to their relative resistance to liver cancer.
- Hormonal status, particularly thyroid hormones, plays a role in sex-specific susceptibility to chemical carcinogens.